Objective value of the apparent diffusion coefficient (ADC) map from ultrahigh b-value diffusion-weighted imaging (DWI) in 3T MRI as a non-invasive predictor for Gleason score in prostate cancer

Read full text Summarise with VIRAT
Authors: Kun Zhang, Zhengming Chen, Chen Zhang, Meifeng Wang, Yonggui Fu, Yun Zhang, Yingying Hu, Yanguang Shen, Huiyi Ye
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Accurate risk stratification of prostate cancer (PCa) is crucial for clinical management. Although diffusion-weighted imaging (DWI) is widely used in PCa evaluation, the value of high and ultrahigh b-values remains under investigation. This study aimed to explore the predictive value of ultrahigh b-value DWI for the Gleason score of PCa patients. Methods: This study gathered a total of 78 patients and acquired T2-weighted imaging (T2WI), conventional DWI (0, 1,000 s/mm2), and ultrahigh b-value DWI (0, 2,000, and 3,000 s/mm2) from each patient. Using reference biopsy as the gold standard, the apparent diffusion coefficient (ADC) of DWI images at different b-values was analyzed. On the basis of regression analysis at various b-values and receiver operating characteristic (ROC) curves, the 3,000 s/mm2 ultrahigh b-value DWI demonstrated greater diagnostic performance in assessing the differentiation of PCa. Results: A total of 154 biopsy-confirmed lesions (102 cancerous lesions and 52 noncancer lesions) were analyzed. Ultrahigh b-value DWI (b=2,000 and 3,000 s/mm2) demonstrated significant differences in ADC values between PCa and noncancerous tissues (P

Fields of Study & Subjects

MRI in cancer diagnosis Prostate Cancer Diagnosis and Treatment Radiomics and Machine Learning in Medical Imaging

Publication details

Journal / source
Quantitative Imaging in Medicine and Surgery
Volume
16
Issue
4
Pages
294–294
Publication date
1 April 2026
Language
EN